Virtu Financial LLC Acquires Shares of 10,085 MeiraGTx Holdings PLC (NASDAQ:MGTX)

Virtu Financial LLC bought a new position in shares of MeiraGTx Holdings PLC (NASDAQ:MGTX) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 10,085 shares of the company’s stock, valued at approximately $174,000.

Several other hedge funds have also recently bought and sold shares of MGTX. SG Americas Securities LLC bought a new position in shares of MeiraGTx during the 4th quarter valued at $138,000. Geode Capital Management LLC increased its stake in shares of MeiraGTx by 54.1% in the 4th quarter. Geode Capital Management LLC now owns 16,625 shares of the company’s stock worth $160,000 after purchasing an additional 5,834 shares in the last quarter. Northern Trust Corp increased its stake in shares of MeiraGTx by 51.7% in the 4th quarter. Northern Trust Corp now owns 40,913 shares of the company’s stock worth $395,000 after purchasing an additional 13,936 shares in the last quarter. Sphera Funds Management LTD. purchased a new stake in shares of MeiraGTx in the 4th quarter worth $686,000. Finally, IFP Advisors Inc increased its stake in shares of MeiraGTx by 3,697.6% in the 4th quarter. IFP Advisors Inc now owns 75,192 shares of the company’s stock worth $725,000 after purchasing an additional 73,212 shares in the last quarter. Hedge funds and other institutional investors own 21.81% of the company’s stock.

MGTX stock traded up $0.01 during trading on Wednesday, reaching $23.99. The company’s stock had a trading volume of 76,800 shares, compared to its average volume of 152,189. MeiraGTx Holdings PLC has a 1 year low of $7.98 and a 1 year high of $24.53. The company has a debt-to-equity ratio of 0.02, a quick ratio of 4.82 and a current ratio of 6.96. The firm has a market capitalization of $799.57 million and a PE ratio of -5.46.

MeiraGTx (NASDAQ:MGTX) last issued its quarterly earnings data on Tuesday, May 14th. The company reported ($0.62) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.64) by $0.02. The firm had revenue of $0.79 million for the quarter. On average, sell-side analysts forecast that MeiraGTx Holdings PLC will post -3.12 EPS for the current fiscal year.

In other news, major shareholder Life Sciences Maste Perceptive acquired 1,304,348 shares of the business’s stock in a transaction dated Friday, March 1st. The stock was purchased at an average price of $13.80 per share, for a total transaction of $18,000,002.40. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Several equities research analysts have recently commented on MGTX shares. Barclays upped their price objective on MeiraGTx from $20.00 to $30.00 and gave the stock a “positive” rating in a research note on Wednesday, May 15th. Zacks Investment Research upgraded MeiraGTx from a “hold” rating to a “buy” rating and set a $20.00 price target for the company in a research note on Saturday, March 30th. Finally, Chardan Capital reiterated a “buy” rating on shares of MeiraGTx in a research note on Tuesday, May 14th. Five research analysts have rated the stock with a buy rating, The company has a consensus rating of “Buy” and an average target price of $27.75.

WARNING: This news story was first reported by Sundance Herald and is the property of of Sundance Herald. If you are reading this news story on another site, it was illegally copied and reposted in violation of US and international trademark & copyright laws. The correct version of this news story can be viewed at https://sundanceherald.com/2019/05/22/virtu-financial-llc-invests-174000-in-meiragtx-holdings-plc-mgtx-stock.html.

MeiraGTx Profile

MeiraGTx Holdings plc, a clinical-stage gene therapy company, focusing on developing treatments for patients living with serious diseases. The company develops various therapies for ocular diseases, including rare inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; neurodegenerative diseases, such as amyothrophic lateral sclerosis; and Parkinson's diseases.

Featured Article: What are different types of coverage ratios?

Institutional Ownership by Quarter for MeiraGTx (NASDAQ:MGTX)

Receive News & Ratings for MeiraGTx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MeiraGTx and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply